Japanese firms see innovation, emerging markets as keys to growth

07/10/2013 | BioSpectrum Asia

Japanese pharmaceutical and life science companies, facing domestic constraints on growth and profits, need to focus on innovation and expanding into emerging markets such as China and India, according to statements by leading industry officials at concurrent meetings of in-Pharma Japan and Interphex Japan in Tokyo. MSD President Tony Alvarez stressed the need to tie innovation to the customer, and Fumiyoshi Sakai of Credit Suisse Securities, Japan, urged companies to invest in markets where economic growth is substantially higher than health care expenditures.

View Full Article in:

BioSpectrum Asia

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT